JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Postoperative radiotherapy for stage pIIIA-N2 non-small cell lung cancer patients undergoing sublobar resection: A retrospective cohort study

  • 0Department of Thoracic Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, P.R. China.
Medicine +

|

February 10, 2025

|

February 10, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Postoperative radiotherapy does not improve survival outcomes for patients with stage pIIIA-N2 non-small cell lung cancer (NSCLC) after sublobar resection. Both cancer-specific survival and overall survival rates were similar between radiotherapy and observation groups.

Area Of Science

  • Oncology
  • Thoracic Surgery
  • Radiation Oncology

Background

  • Stage pIIIA-N2 non-small cell lung cancer (NSCLC) presents a complex treatment challenge.
  • Sublobar resection is sometimes employed for early-stage NSCLC, but its optimal use in advanced stages requires further investigation.
  • The role of adjuvant therapies, such as postoperative radiotherapy, in improving survival after sublobar resection for N2 disease remains debated.

Purpose Of The Study

  • To evaluate the impact of postoperative radiotherapy on survival outcomes in patients with stage pIIIA-N2 NSCLC who underwent sublobar resection.
  • To compare cancer-specific survival (CSS) and overall survival (OS) between patients receiving postoperative radiotherapy and those under observation.
  • To analyze survival differences in subgroups based on the administration of postoperative chemotherapy.

Main Methods

  • Retrospective analysis of patient data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2020).
  • Inclusion criteria: patients diagnosed with stage pIIIA-N2 NSCLC treated with sublobar resection.
  • Comparison of CSS and OS using survival analysis, calculating hazard ratios (HR) and 95% confidence intervals (CI).

Main Results

  • A total of 444 patients were analyzed: 210 (47.3%) received postoperative radiotherapy, and 234 (52.7%) were observed.
  • No significant difference in CSS (HR=0.99, P=0.926) or OS (HR=0.93, P=0.512) was observed between the radiotherapy and observation groups.
  • Subgroup analyses for patients who received or did not receive postoperative chemotherapy also showed no significant survival differences between the radiotherapy and observation groups.

Conclusions

  • Postoperative radiotherapy does not appear to improve cancer-specific survival or overall survival in patients with stage pIIIA-N2 NSCLC following sublobar resection.
  • The findings suggest that observation may be a suitable alternative to postoperative radiotherapy in this specific patient population.
  • Further research may be warranted to explore alternative treatment strategies or refine patient selection for adjuvant therapies in this setting.